# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-22-044926
Filing Date
2022-02-17
Accepted
2022-02-17 08:01:13
Documents
38
Period of Report
2022-02-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d296665d8k.htm iXBRL | 8-K | 42423
2 | EX-99.1 | d296665dex991.htm | EX-99.1 | 32645
3 | EX-99.2 | d296665dex992.htm | EX-99.2 | 32448
7 | GRAPHIC | g296665ex99_2s10g1.jpg | GRAPHIC | 164637
8 | GRAPHIC | g296665ex99_2s11g1.jpg | GRAPHIC | 244377
9 | GRAPHIC | g296665ex99_2s12g1.jpg | GRAPHIC | 231530
10 | GRAPHIC | g296665ex99_2s13g1.jpg | GRAPHIC | 241254
11 | GRAPHIC | g296665ex99_2s14g1.jpg | GRAPHIC | 240106
12 | GRAPHIC | g296665ex99_2s15g1.jpg | GRAPHIC | 231146
13 | GRAPHIC | g296665ex99_2s16g1.jpg | GRAPHIC | 256700
14 | GRAPHIC | g296665ex99_2s17g1.jpg | GRAPHIC | 163078
15 | GRAPHIC | g296665ex99_2s18g1.jpg | GRAPHIC | 278808
16 | GRAPHIC | g296665ex99_2s19g1.jpg | GRAPHIC | 283110
17 | GRAPHIC | g296665ex99_2s1g1.jpg | GRAPHIC | 270032
18 | GRAPHIC | g296665ex99_2s20g1.jpg | GRAPHIC | 234668
19 | GRAPHIC | g296665ex99_2s21g1.jpg | GRAPHIC | 249356
20 | GRAPHIC | g296665ex99_2s22g1.jpg | GRAPHIC | 234044
21 | GRAPHIC | g296665ex99_2s23g1.jpg | GRAPHIC | 186168
22 | GRAPHIC | g296665ex99_2s2g1.jpg | GRAPHIC | 352443
23 | GRAPHIC | g296665ex99_2s3g1.jpg | GRAPHIC | 292014
24 | GRAPHIC | g296665ex99_2s4g1.jpg | GRAPHIC | 253379
25 | GRAPHIC | g296665ex99_2s5g1.jpg | GRAPHIC | 286647
26 | GRAPHIC | g296665ex99_2s6g1.jpg | GRAPHIC | 295466
27 | GRAPHIC | g296665ex99_2s7g1.jpg | GRAPHIC | 238532
28 | GRAPHIC | g296665ex99_2s8g1.jpg | GRAPHIC | 162018
29 | GRAPHIC | g296665ex99_2s9g1.jpg | GRAPHIC | 290851
30 | GRAPHIC | g296665g77y52.jpg | GRAPHIC | 3132
| Complete submission text file | 0001193125-22-044926.txt |  | 8084001

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | arvn-20220217.xsd | EX-101.SCH | 2857
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | arvn-20220217_lab.xml | EX-101.LAB | 17995
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | arvn-20220217_pre.xml | EX-101.PRE | 11262
32 | EXTRACTED XBRL INSTANCE DOCUMENT | d296665d8k_htm.xml | XML | 3353

Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 22645693
SIC: 2834 Pharmaceutical Preparations